Show
Sort by
-
Treatment of central sensitization in patients with chronic pain : time for change?
-
Effect of a sequential treatment combining abaloparatide and alendronate for the management of postmenopausal osteoporosis
-
Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis
-
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
-
Treatment of central sensitization in patients with 'unexplained' chronic pain: an update
-
Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have?
-
Pediatric HIV : new opportunities to treat children
-
Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting
-
Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients
-
Pemetrexed in thoracic cancer